1731-7398 Premenstrual syndrome: a short review Ziomkiewicz-Wichary Anna author Zakład Antropologii, Instytut Immunologii i Terapii Doświadczalnej Polskiej Akademii Nauk, 50-449 Wrocław, ul. Podwale 75 Correspondence to: Anna Ziomkiewicz-Wichary annaziomkiewicz@gmail.com 28 08 2017 Tom 15, Numer 2 2017 156 160 Copyright © 2017 2017 Przygotowanie do wydania elektronicznego publikacji - zadanie finansowane w ramach umowy Nr 780/P-DUN/2017 ze środków Ministra Nauki i Szkolnictwa Wyższego przeznaczonych na działalność upowszechniającą naukę. <div id="cke_pastebin">Premenstrual syndrome (PMS) is a complex cluster of physical and behavioral symptoms that occur during the late luteal phase of the menstrual cycle in reproductive age women. PMS is inextricably associated with ovulation. Not only pregnancy blocks premenstrual symptoms but also in anovulatory cycles symptoms seem to disappear. It is diagnosed in up to 80% women, worldwide, with around 8% of women suffering from its most severe form – premenstrual disphoric disorder. Although this syndrome has been investigated for almost 60 years, researchers are still far from full understanding of this psycho-somatic condition. Some even question its biological basis and attribute it to specific role that women play in western society and culture. This short review summarizes past and current scientific perspective on PMS, including its etiology and physiology. This paper also discusses evolutionary hypotheses proposed to explain the universal occurrence of premenstrual symptoms in women worldwide.<span style="font-size: 10pt;"></span></div> 1 World Health Organization, The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research, Geneva, 1993. 2 American Psychiatric Association, Diagnostic and statistical manual of mental disorders (DSM-5®), American Psychiatric Association Publishing, England, 2013. 3 Perez-Lopez F.R., Chedraui P., Perez-Roncero G., Lopez- 4 -Baena M.T., Cuadros-Lopez J.L., Premenstrual syndrome and premenstrual dysphoric disorder: Symptoms and cluster influences, “Open Journal of Psychiatry” 2009; 3 (1): 39–49. 5 Greene R., Dalton K., The premenstrual syndrome, “British Medical Journal” 19531; 4818: 1007. 6 Stolberg M., The monthly malady: a history of premenstrual suffering, “Medical History” 2000; 44 (3): 301–322. 7 Horstmanshoff M., King H., Zittel C., Blood, Sweat and Tears–The Changing Concepts of Physiology from Antiquity into Early Modern Europe, Brill, Netherlands, 2012: 443–478. 8 Lord A.M., The Great Arcana of the Deity: Menstruation and Menstrual Disorders in Eighteenth-Century British Medical Thought, ”Bulletin of the History of Medicine” 1999; 73 (1): 38–63. 9 Richardson J.T., The premenstrual syndrome: a brief history, “Social Science &amp; Medicine” 1995; 41 (6): 761–767. 10 Rodin M., The social construction of premenstrual syndrome, “Social Science &amp; Medicine” 1992; 35 (1): 49–56. 11 Bäckström T., Andreen L., Birzniece V., Björn I., Johansson I.M., Nordenstam-Haghjo M., Nyberg S., Sundström-Poromaa I., Wahlström G., Wang M., Zhu D., The role of hormones and hormonal treatments in premenstrual syndrome, “CNS Drugs” 2003; 17 (5): 325–342. 12 Doyle C., Ewald H.A.S., Ewald P.W., Premenstrual syndrome: An evolutionary perspective on its causes and treatment, “Perspectives in Biology and Medicine” 2007; 50 (2): 181–202. 13 Andréen L., Nyberg S., Turkmen S., van Wingen G., Fernández G., Bäckström T., Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABA A modulators, “Psychoneuroendocrinology” 2009; 34 (8): 1121–1132. 14 Rapkin A.J., Akopians A.L., Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder, “Menopause International” 2012; 18 (2): 52–59. 15 Dennerstein L., Spencer-Gardner C., Brown J.B., Smith M.A., Burrows G.D., Premenstrual tension-hormonal profiles, “Journal of Psychosomatic Obstetrics &amp; Gynecology” 1984; 3 (1): 37–51. 16 Munday M.R., Brush M.G., Taylor R.W., Correlations between progesterone, oestradiol and aldosterone levels in the premenstrual syndrome, “Clinical Endocrinology” 1981; 14 (1): 1–9. 17 Eriksson E., Sundblad C., Lisjö P., Modigh K., Andersch B., Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls, “Psychoneuroendocrinology” 1992; 17 (2): 195–204. 18 Redei E., Freeman E.W., Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms,“Psychoneuroendocrinology” 1995; 20 (3): 259–267. 19 Ziomkiewicz A., Pawlowski B., Ellison P.T., Lipson S.F., Thune I., Jasienska G., Higher luteal progesterone is associated with low levels of premenstrual aggressive behavior and fatigue, “Biological Psychology” 2012; 91 (3): 376–382. 20 Gold E.B., Wells C., Rasor M.O.N., The association of inflammation with premenstrual symptoms, “Journal of Women’s Health” 2016; 25 (9): 865–874. 21 Puder J.J., Blum C.A., Mueller B., Geyter C., Dye L., Keller U., Menstrual cycle symptoms are associated with changes in low – grade inflammation,“European Journal of Clinical Investigation” 2006; 36 (1): 58–64. 22 Bertone-Johnson E.R., Ronnenberg A.G., Houghton S.C., Nobles C., Zagarins S.E., Takashima-Uebelhoer B.B., Faraj J.L., Whitcomb B.W., Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women, ”Human Reproduction” 2014; 29 (9): 1987–1994 23 He J., Evans C.O., Hoffman S.W., Oyesiku N.M., Stein D.G., Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury, “Experimental Neurology” 2004; 189 (2): 404–412. 24 Pettus E.H., Wright D.W., Stein D.G., Hoffman S.W., Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury, “Brain Research” 2005; 1049 (1): 112–119. 25 Kelly R.W., Illingworth P., Baldie G., Leask R., Brouwer S., Calder A.A., Progesterone control of interleukin-8 production in endometrium and chorio-decidual cells underlines the role of the neutrophil in menstruation and parturition, “Human Reproduction” 1994; 9 (2): 253–258. 26 Aisemberg J., Vercelli C.A., Bariani M.V., Billi S.C., Wolfson M.L., Franchi A.M., Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone, “PLoS One” 2013; 8 (2): e56161. 27 Rosseinsky D.R., Hall P.G., An evolutionary theory of premenstrual tension, “The Lancet” 1974; 304 (7887): 1024. 28 Morriss G., Keverne E.B., Premenstrual tension, “The Lancet” 1974; 304 (7892): 1317–1318. 29 Gillings M.R., Were there evolutionary advantages to premenstrual syndrome? “Evolutionary Applications” 2014; 7 (8): 897–904. 30 Reiber C., An evolutionary model of premenstrual syndrome, “Medical Hypotheses” 2008; 70 (5): 1058–1065.